商用富血小板血浆(PRP)系统浓度产率综述:呼吁PRP标准化
该系统综述从876项研究中筛选13项,提取并标准化33种PRP系统与制备方案的数据,比较血小板、白细胞及生长因子浓度。结果显示各系统间PRP终产物浓度与制备方案差异很大,但血小板浓度与采集血量和设备离心力直接相关。作者结论是PRP分离系统间存在很大异质性,需解决以实现标准化研究。
要点
- 不同商用PRP系统的终产物浓度与制备方案差异很大。
- 血小板浓度与采集血量和设备离心力直接相关。
- PRP研究亟需报告与制备方案标准化。
核心结论
- PRP分离系统间存在很大异质性,必须解决以支持对该疗法的规范研究。
研究设计与样本
- 系统综述,检索876项研究后按纳入标准选取13项研究。
- 从33种PRP系统与制备方案中提取并标准化血小板、白细胞及生长因子数据。
主要发现
- 各系统间PRP终产物浓度及制备方案差异很大。
- 血小板浓度与采集血量和设备离心力直接相关。
关键数值与推荐
- 纳入13项研究,提取33种PRP系统与方案的数据进行标准化比较。
临床怎么用
- 临床选用PRP系统时应关注其制备方案与终产物浓度差异,不宜跨系统直接比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platelet-rich plasma (PRP) has become increasingly popular in pain medicine with hopes of becoming a safe, effective alternative to routine treatments. However, given its autologous nature, PRP injectate may differ depending on the specific manufacturer and protocol. Currently, there is no standardization of reporting protocol. This systematic review compiles and standardizes values on PRP preparation and final product composition of platelets, white cell count, and growth factors for ease of comparison. On review of 876 studies, 13 studies were selected according to our inclusion criteria. Data from 33 PRP systems and protocols were extracted and standardized. Overall, PRP final product concentrations as well as PRP preparation protocols varied widely between systems. However, platelet concentration was directly correlated with both volume of blood collected and device centrifugal force. In conclusion, there is a large heterogeneity between PRP separation systems that must be resolved for proper study of this promising treatment.
引用
- Fadadu PP, Mazzola AJ, Hunter CW, et al. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med. 2019. PMID: 30992411. doi:10.1136/rapm-2018-100356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。